Protease and Inhibitor Mechanisms
Matrix metalloproteinases are a family of zinc-dependent enzymes that cut through the proteins surrounding cells, allowing tissues to remodel themselves during normal development and wound healing—but also enabling tumors to invade neighboring tissue and establish new blood supplies. Their natural counterparts, the tissue inhibitors of metalloproteinases, maintain a careful balance that, when disrupted, tips cellular environments toward chronic inflammation and unchecked cancer progression. Researchers are working to understand how MMPs selectively activate growth signals and reshape the extracellular matrix at different stages of tumor development, since the same enzyme can suppress early tumors while promoting metastasis later. A central challenge is designing inhibitors that block harmful MMP activity without interfering with the protective roles these enzymes play in ordinary tissue maintenance and immune response.
- Works
- 77,413
- Total citations
- 1,994,815
- Keywords
- Matrix MetalloproteinasesTissue Inhibitors of MetalloproteinasesCancer ProgressionAngiogenesisExtracellular Matrix RemodelingProtease Inhibition
Top papers in Protease and Inhibitor Mechanisms
Ordered by total citation count.
- Tissue Plasminogen Activator for Acute Ischemic Stroke↗ 11,695
- The pathogenesis of atherosclerosis: a perspective for the 1990s↗ 10,686
- New functions for the matrix metalloproteinases in cancer progression↗ 6,082
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment↗ 5,068OA
- Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases↗ 4,535OA
- Remodelling the extracellular matrix in development and disease↗ 4,399OA
- How Matrix Metalloproteinases Regulate Cell Behavior↗ 3,933OA
- Matrix Metalloproteinases↗ 3,899OA
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation↗ 3,603
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome↗ 3,559OA
- Structure and function of matrix metalloproteinases and TIMPs↗ 3,402
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma↗ 3,354
Active researchers
Top authors in this area, ranked by h-index.